Review



flow cytometry staining buffer  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Thermo Fisher flow cytometry staining buffer
    Macrophage polarization in the spleen and mesenteric lymph nodes (MLN) of T. spiralis -infected mice with or without Ts -Hsp70 immunization Splenocytes and MLN cells were collected from T. spiralis -infected mice ( T.S. group) and Ts -Hsp70−immunized infected mice ( T.S. + Ts -Hsp70 group) at 1, 5, 15, and 30 days post−infection (dpi) and analyzed by flow <t>cytometry.</t> (A) Representative flow cytometry plots of M1 (CD11b + F4/80 + iNOS + ) and M2 (CD11b + F4/80 + CD206 + ) macrophages in the spleen. (B–D) Quantitative analysis of M1 macrophage percentage (B) , M2 macrophage percentage (C) , and M1/M2 ratio (D) in splenocytes. (E) Representative flow cytometry plots of M1 and M2 macrophages in the MLN. (F–H) Quantitative analysis of M1 macrophage percentage (F) , M2 macrophage percentage (G) , and M1/M2 ratio (H) in MLN cells. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t−tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.
    Flow Cytometry Staining Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Matrix+DeepWell+Storage+Blocks/pmc13111117-91-9-16
    Average 97 stars, based on 1 article reviews
    flow cytometry staining buffer - by Bioz Stars, 2026-10
    97/100 stars

    Images

    1) Product Images from "Ts -Hsp70 confers dual-stage protective immunity against Trichinella spiralis infection by sustaining M1 macrophage polarization in mice"

    Article Title: Ts -Hsp70 confers dual-stage protective immunity against Trichinella spiralis infection by sustaining M1 macrophage polarization in mice

    Journal: Frontiers in Immunology

    doi: 10.3389/fimmu.2026.1799793

    Macrophage polarization in the spleen and mesenteric lymph nodes (MLN) of T. spiralis -infected mice with or without Ts -Hsp70 immunization Splenocytes and MLN cells were collected from T. spiralis -infected mice ( T.S. group) and Ts -Hsp70−immunized infected mice ( T.S. + Ts -Hsp70 group) at 1, 5, 15, and 30 days post−infection (dpi) and analyzed by flow cytometry. (A) Representative flow cytometry plots of M1 (CD11b + F4/80 + iNOS + ) and M2 (CD11b + F4/80 + CD206 + ) macrophages in the spleen. (B–D) Quantitative analysis of M1 macrophage percentage (B) , M2 macrophage percentage (C) , and M1/M2 ratio (D) in splenocytes. (E) Representative flow cytometry plots of M1 and M2 macrophages in the MLN. (F–H) Quantitative analysis of M1 macrophage percentage (F) , M2 macrophage percentage (G) , and M1/M2 ratio (H) in MLN cells. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t−tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.
    Figure Legend Snippet: Macrophage polarization in the spleen and mesenteric lymph nodes (MLN) of T. spiralis -infected mice with or without Ts -Hsp70 immunization Splenocytes and MLN cells were collected from T. spiralis -infected mice ( T.S. group) and Ts -Hsp70−immunized infected mice ( T.S. + Ts -Hsp70 group) at 1, 5, 15, and 30 days post−infection (dpi) and analyzed by flow cytometry. (A) Representative flow cytometry plots of M1 (CD11b + F4/80 + iNOS + ) and M2 (CD11b + F4/80 + CD206 + ) macrophages in the spleen. (B–D) Quantitative analysis of M1 macrophage percentage (B) , M2 macrophage percentage (C) , and M1/M2 ratio (D) in splenocytes. (E) Representative flow cytometry plots of M1 and M2 macrophages in the MLN. (F–H) Quantitative analysis of M1 macrophage percentage (F) , M2 macrophage percentage (G) , and M1/M2 ratio (H) in MLN cells. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t−tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.

    Techniques Used: Infection, Flow Cytometry

    Expression of M1 and M2 polarization markers in peritoneal macrophages stimulated with Ts -Hsp70 protein Peritoneal macrophages isolated from naïve mice were incubated in vitro with PBS (Control), Ts -Hsp70 protein, LPS (M1 inducer), or IL−4 (M2 inducer). (A) mRNA levels of M1 markers (iNOS, TNF-α, IL−12) and M2 markers (Arg−1, Ym−1, TGF−β) measured by RT−qPCR after 24 h. Protein expression was analyzed by flow cytometry after 24 h. (B) Representative flow cytometry dot plots showing gated macrophages for M1/M2 marker analysis. (C) Surface expression of CD80 (M1 marker). (D) Intracellular expression of iNOS (M1 marker). (E) Surface expression of CD206 (M2 marker). (F) Intracellular expression of Arg−1 (M2 marker). Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t-tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.
    Figure Legend Snippet: Expression of M1 and M2 polarization markers in peritoneal macrophages stimulated with Ts -Hsp70 protein Peritoneal macrophages isolated from naïve mice were incubated in vitro with PBS (Control), Ts -Hsp70 protein, LPS (M1 inducer), or IL−4 (M2 inducer). (A) mRNA levels of M1 markers (iNOS, TNF-α, IL−12) and M2 markers (Arg−1, Ym−1, TGF−β) measured by RT−qPCR after 24 h. Protein expression was analyzed by flow cytometry after 24 h. (B) Representative flow cytometry dot plots showing gated macrophages for M1/M2 marker analysis. (C) Surface expression of CD80 (M1 marker). (D) Intracellular expression of iNOS (M1 marker). (E) Surface expression of CD206 (M2 marker). (F) Intracellular expression of Arg−1 (M2 marker). Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t-tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.

    Techniques Used: Expressing, Isolation, Incubation, In Vitro, Control, Quantitative RT-PCR, Flow Cytometry, Marker

    Effects of Ts -Hsp70 on macrophage-induced T lymphocyte proliferation and phagocytosis (A, B) Macrophage-induced CD4 + T cell proliferation. Splenocytes from wild-type mice were labeled with CFSE and co-cultured for 72 h with peritoneal macrophages pre-stimulated with PBS, Ts -Hsp70, LPS, or IL-4. Proliferation of CD4 + T cells was analyzed by flow cytometry based on CFSE dilution. (A) Representative histograms of CFSE fluorescence in CD4 + T cells. (B) Statistical summary of CD4 + T cell proliferation. (C, D) Phagocytic activity of peritoneal macrophages. Peritoneal macrophages stimulated in vitro with PBS, Ts -Hsp70, LPS, or IL-4 were incubated with FITC-dextran for 30 minutes. Phagocytosis was quantified by flow cytometry as the percentage of Dextran + F4/80 + macrophages. (C) Representative flow cytometry plots of Dextran + F4/80 + macrophages. (D) Statistical summary of the percentage of Dextran + F4/80 + macrophages. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t-tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.
    Figure Legend Snippet: Effects of Ts -Hsp70 on macrophage-induced T lymphocyte proliferation and phagocytosis (A, B) Macrophage-induced CD4 + T cell proliferation. Splenocytes from wild-type mice were labeled with CFSE and co-cultured for 72 h with peritoneal macrophages pre-stimulated with PBS, Ts -Hsp70, LPS, or IL-4. Proliferation of CD4 + T cells was analyzed by flow cytometry based on CFSE dilution. (A) Representative histograms of CFSE fluorescence in CD4 + T cells. (B) Statistical summary of CD4 + T cell proliferation. (C, D) Phagocytic activity of peritoneal macrophages. Peritoneal macrophages stimulated in vitro with PBS, Ts -Hsp70, LPS, or IL-4 were incubated with FITC-dextran for 30 minutes. Phagocytosis was quantified by flow cytometry as the percentage of Dextran + F4/80 + macrophages. (C) Representative flow cytometry plots of Dextran + F4/80 + macrophages. (D) Statistical summary of the percentage of Dextran + F4/80 + macrophages. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by multiple t-tests: ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.

    Techniques Used: Labeling, Cell Culture, Flow Cytometry, Fluorescence, Activity Assay, In Vitro, Incubation

    Related Articles

    Staining:

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243). .. The CD34 − fraction was stained with the following antibodies in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), FITC anti‐human CD33 antibody (clone P67.6, Biolegend Cat# 366619), PE anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318305), and PE/Cy7 anti‐human CD20 antibody (clone 2H7, Biolegend Cat# 302311). .. Cells were incubated on ice for 20 min, washed twice with Flow Cytometry Staining Buffer, and resuspended in diluted SYTOX AADvanced (ThermoFisher Cat# S10274 ) to exclude dead cells.

    Article Title: Ts -Hsp70 confers dual-stage protective immunity against Trichinella spiralis infection by sustaining M1 macrophage polarization in mice
    Article Snippet: .. After supernatant removal, pellets were resuspended in 2 mL Flow Cytometry Staining Buffer (Catalog #: 00-4222-26, eBioscience, San Diego, CA, USA), centrifuged again (500 × g, 5 min, RT), and finally resuspended in Flow Cytometry Staining Buffer. .. Prior to surface staining, cells were incubated with an Fc Block (anti-mouse CD16/32, Catalog #: 14-0161-86, eBioscience, San Diego, CA, USA) to minimize non-specific binding.

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: .. FLs were dissociated in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26) using a 21G × 15 mm needle attached to a syringe (BD Microlance Cat# 10472204‐X and 3000185) and further CD34‐enriched using the CD34 MicroBead Kit Ultrapure human (Millitenyi Cat# 130‐100‐453) according to the manufacturer's instructions. .. The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243).

    Article Title: Protocol for isolating and culturing microglia from the adult mouse brain using a magnetic-activated cell sorting system
    Article Snippet: .. Note: We use commercial flow cytometry staining buffer from eBioscience (Cat# 00-4222-26), which is PBS-based formulation designed to prevent non-specific antibody binding and maintain cell stability during flow cytometry. ..

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: FLs were dissociated in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26) using a 21G × 15 mm needle attached to a syringe (BD Microlance Cat# 10472204‐X and 3000185) and further CD34‐enriched using the CD34 MicroBead Kit Ultrapure human (Millitenyi Cat# 130‐100‐453) according to the manufacturer's instructions. .. The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243). .. The CD34 − fraction was stained with the following antibodies in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), FITC anti‐human CD33 antibody (clone P67.6, Biolegend Cat# 366619), PE anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318305), and PE/Cy7 anti‐human CD20 antibody (clone 2H7, Biolegend Cat# 302311).

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: PER‐494 (CVCL_A8JU), RS4;11 (ATCC®CRL‐1873TM), SEM (DSMZ ACC 546), Nalm6 (ATCC®CRL‐3273TM), MV4;11 (ATCC®CRL‐9591TM), MOLM‐13 (DSMZ ACC 554), THP‐1 (ATCC®TIB‐200TM), Nomo‐1 (DSMZ ACC 542), and Kasumi1 (ATCC®CRL‐2724TM) cells were maintained in 20% fetal calf serum (FCS) 1% P/S 1% l ‐glut RPMI (Roswell Park Memorial Institute) 1640 (cells kindly provided by Professor Mark Dawson, Professor Brian Huntly, and Dr. Rishi Sury Kotecha). .. Dissociated FL cells were stained using the following antibody mix in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐mouse CD117 (ckit) antibody (clone 2B8, Biolegend Cat# 105811), FITC rat anti‐mouse CD34 (clone RAM34, BD Cat# 560238), and PE CD45 monoclonal antibody eBioscienceTM (clone 30‐F11, ThemoFisher Cat# 12‐0451‐82). .. Cells were incubated with the antibodies for 20 min on ice, washed twice with Flow Cytometry Staining Buffer, and resuspended in diluted SYTOX AADvanced (ThermoFisher Cat# S10274 ) to exclude dead cells.

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: Lineage depletion was performed on dissociated FL cells using the EasySepTM Mouse Hematopoietic Progenitor Cell Isolation Kit (STEMCELL Technologies Cat# 19856) according to the manufacturer's instructions. .. Cells were stained using the following antibody mix in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): FITC anti‐mouse CD45 antibody (clone 30‐F11, Biolegend Cat# 103017), APC anti‐mouse CD48 antibody (clone HM48‐1, Biolegend Cat# 103411), Pacific BlueTM anti‐mouse CD150 antibody (clone TC15‐12F12.2, Biolegend Cat# 115923), and PE anti‐mouse EPCR monoclonal antibody (clone eBio1560 [1560], ThermoFisher Cat# 12‐2012‐82). ..

    Article Title: Protocol for isolating and culturing microglia from the adult mouse brain using a magnetic-activated cell sorting system
    Article Snippet: ArCTM Amine Reactive Compensation , eBioscience , Cat#A10346. .. Flow Cytometry Staining Buffer , eBioscience , Cat#00-4222-26. .. 2X Universal SYBR Green Mix , ABclonal , Cat#RK21203.

    Flow Cytometry:

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243). .. The CD34 − fraction was stained with the following antibodies in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), FITC anti‐human CD33 antibody (clone P67.6, Biolegend Cat# 366619), PE anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318305), and PE/Cy7 anti‐human CD20 antibody (clone 2H7, Biolegend Cat# 302311). .. Cells were incubated on ice for 20 min, washed twice with Flow Cytometry Staining Buffer, and resuspended in diluted SYTOX AADvanced (ThermoFisher Cat# S10274 ) to exclude dead cells.

    Article Title: Ts -Hsp70 confers dual-stage protective immunity against Trichinella spiralis infection by sustaining M1 macrophage polarization in mice
    Article Snippet: .. After supernatant removal, pellets were resuspended in 2 mL Flow Cytometry Staining Buffer (Catalog #: 00-4222-26, eBioscience, San Diego, CA, USA), centrifuged again (500 × g, 5 min, RT), and finally resuspended in Flow Cytometry Staining Buffer. .. Prior to surface staining, cells were incubated with an Fc Block (anti-mouse CD16/32, Catalog #: 14-0161-86, eBioscience, San Diego, CA, USA) to minimize non-specific binding.

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: .. FLs were dissociated in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26) using a 21G × 15 mm needle attached to a syringe (BD Microlance Cat# 10472204‐X and 3000185) and further CD34‐enriched using the CD34 MicroBead Kit Ultrapure human (Millitenyi Cat# 130‐100‐453) according to the manufacturer's instructions. .. The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243).

    Article Title: Protocol for isolating and culturing microglia from the adult mouse brain using a magnetic-activated cell sorting system
    Article Snippet: .. Note: We use commercial flow cytometry staining buffer from eBioscience (Cat# 00-4222-26), which is PBS-based formulation designed to prevent non-specific antibody binding and maintain cell stability during flow cytometry. ..

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: FLs were dissociated in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26) using a 21G × 15 mm needle attached to a syringe (BD Microlance Cat# 10472204‐X and 3000185) and further CD34‐enriched using the CD34 MicroBead Kit Ultrapure human (Millitenyi Cat# 130‐100‐453) according to the manufacturer's instructions. .. The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243). .. The CD34 − fraction was stained with the following antibodies in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), FITC anti‐human CD33 antibody (clone P67.6, Biolegend Cat# 366619), PE anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318305), and PE/Cy7 anti‐human CD20 antibody (clone 2H7, Biolegend Cat# 302311).

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: PER‐494 (CVCL_A8JU), RS4;11 (ATCC®CRL‐1873TM), SEM (DSMZ ACC 546), Nalm6 (ATCC®CRL‐3273TM), MV4;11 (ATCC®CRL‐9591TM), MOLM‐13 (DSMZ ACC 554), THP‐1 (ATCC®TIB‐200TM), Nomo‐1 (DSMZ ACC 542), and Kasumi1 (ATCC®CRL‐2724TM) cells were maintained in 20% fetal calf serum (FCS) 1% P/S 1% l ‐glut RPMI (Roswell Park Memorial Institute) 1640 (cells kindly provided by Professor Mark Dawson, Professor Brian Huntly, and Dr. Rishi Sury Kotecha). .. Dissociated FL cells were stained using the following antibody mix in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐mouse CD117 (ckit) antibody (clone 2B8, Biolegend Cat# 105811), FITC rat anti‐mouse CD34 (clone RAM34, BD Cat# 560238), and PE CD45 monoclonal antibody eBioscienceTM (clone 30‐F11, ThemoFisher Cat# 12‐0451‐82). .. Cells were incubated with the antibodies for 20 min on ice, washed twice with Flow Cytometry Staining Buffer, and resuspended in diluted SYTOX AADvanced (ThermoFisher Cat# S10274 ) to exclude dead cells.

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: Lineage depletion was performed on dissociated FL cells using the EasySepTM Mouse Hematopoietic Progenitor Cell Isolation Kit (STEMCELL Technologies Cat# 19856) according to the manufacturer's instructions. .. Cells were stained using the following antibody mix in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): FITC anti‐mouse CD45 antibody (clone 30‐F11, Biolegend Cat# 103017), APC anti‐mouse CD48 antibody (clone HM48‐1, Biolegend Cat# 103411), Pacific BlueTM anti‐mouse CD150 antibody (clone TC15‐12F12.2, Biolegend Cat# 115923), and PE anti‐mouse EPCR monoclonal antibody (clone eBio1560 [1560], ThermoFisher Cat# 12‐2012‐82). ..

    Article Title: Protocol for isolating and culturing microglia from the adult mouse brain using a magnetic-activated cell sorting system
    Article Snippet: ArCTM Amine Reactive Compensation , eBioscience , Cat#A10346. .. Flow Cytometry Staining Buffer , eBioscience , Cat#00-4222-26. .. 2X Universal SYBR Green Mix , ABclonal , Cat#RK21203.

    Formulation:

    Article Title: Protocol for isolating and culturing microglia from the adult mouse brain using a magnetic-activated cell sorting system
    Article Snippet: .. Note: We use commercial flow cytometry staining buffer from eBioscience (Cat# 00-4222-26), which is PBS-based formulation designed to prevent non-specific antibody binding and maintain cell stability during flow cytometry. ..

    Binding Assay:

    Article Title: Protocol for isolating and culturing microglia from the adult mouse brain using a magnetic-activated cell sorting system
    Article Snippet: .. Note: We use commercial flow cytometry staining buffer from eBioscience (Cat# 00-4222-26), which is PBS-based formulation designed to prevent non-specific antibody binding and maintain cell stability during flow cytometry. ..

    Recombinase Polymerase Amplification:

    Article Title: A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP‐ALL uncovers novel therapeutic targets
    Article Snippet: FLs were dissociated in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26) using a 21G × 15 mm needle attached to a syringe (BD Microlance Cat# 10472204‐X and 3000185) and further CD34‐enriched using the CD34 MicroBead Kit Ultrapure human (Millitenyi Cat# 130‐100‐453) according to the manufacturer's instructions. .. The CD34 + fraction was stained with the following antibodies (lineage cocktail on APC) in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): APC anti‐human CD2 antibody (clone RPA‐2.10, Biolegend Cat# 300213), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), APC anti‐human CD14 antibody (clone M5E2, Biolegend Cat# 301807), APC anti‐human CD16 antibody (clone 3G8, Biolegend Cat# 302011), APC anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318309), APC anti‐human CD235ab antibody (clone HIR2, Biolegend Cat# 306607), Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), PE anti‐human CD45RA antibody (clone HI100, Biolegend Cat# 304107), PE/Cy7 anti‐human CD10 antibody (clone eBIOCB‐CALLA, ThermoFisher Cat# 25‐0106‐42), BrilliantVioletTM 421 anti‐human CD90 (clone 5E10, Biolegend Cat# 328121), BrilliantVioletTM 510 anti‐human CD38 (clone HB7, Biolegend Cat# 356633), and BrilliantVioletTM 605 anti‐human CD19 (clone HIB19, Biolegend Cat# 302243). .. The CD34 − fraction was stained with the following antibodies in Flow Cytometry Staining Buffer (ThermoFisher Cat# 00‐4222‐26): Alexa Fluor® 700 anti‐human CD34 antibody (clone 561, Biolegend Cat# 343621), APC anti‐human CD3 antibody (clone HIT3, Biolegend Cat# 300311), FITC anti‐human CD33 antibody (clone P67.6, Biolegend Cat# 366619), PE anti‐human CD56 antibody (clone HCD56, Biolegend Cat# 318305), and PE/Cy7 anti‐human CD20 antibody (clone 2H7, Biolegend Cat# 302311).



    Similar Products

    94
    Shanghai Korain Biotech Co Ltd ctrp3
    Ctrp3, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Rat+Matrix+Metalloproteinase-16/10__3390_slash_biomedicines14102223-112-234-238
    Average 94 stars, based on 1 article reviews
    ctrp3 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Geistlich Pharma AG collagen matrix (mucograft seal
    Collagen Matrix (Mucograft Seal, supplied by Geistlich Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/collagen+matrix/nct04741607-18-7-11
    Average 90 stars, based on 1 article reviews
    collagen matrix (mucograft seal - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    95
    R&D Systems matrix metallopeptidase 9
    Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and <t>MMP9</t> determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
    Matrix Metallopeptidase 9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Human+MMP-9+DuoSet+ELISA/pmc13054578-81-14-19
    Average 95 stars, based on 1 article reviews
    matrix metallopeptidase 9 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    98
    Thermo Fisher filmtracertm syprotm ruby biofilm matrix stain
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Filmtracertm Syprotm Ruby Biofilm Matrix Stain, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Concanavalin+A/pmc13320429-86-21-27
    Average 98 stars, based on 1 article reviews
    filmtracertm syprotm ruby biofilm matrix stain - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    95
    Valiant Co Ltd matrix tube
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Matrix Tube, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Empty+FastPrep+2mL+Lysing+Matrix+tubes/pmc13644388-270-18-20
    Average 95 stars, based on 1 article reviews
    matrix tube - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    98
    Valiant Co Ltd matrix e tube
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Matrix E Tube, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Lysing+Matrix+E/pm41697102-61-8-11
    Average 98 stars, based on 1 article reviews
    matrix e tube - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    96
    Valiant Co Ltd lysing matrix a
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Lysing Matrix A, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Lysing+Matrix+A/pmc13651322-75-27-31
    Average 96 stars, based on 1 article reviews
    lysing matrix a - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    98
    Valiant Co Ltd lysing matrix e tubes
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Lysing Matrix E Tubes, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/Lysing+Matrix+E/pmc13633974-159-11-15
    Average 98 stars, based on 1 article reviews
    lysing matrix e tubes - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    99
    Valiant Co Ltd lysing matrix h tube
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Lysing Matrix H Tube, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/FastPrep-24+Classic/pm42816495-339-6-10
    Average 99 stars, based on 1 article reviews
    lysing matrix h tube - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    94
    Valiant Co Ltd matrix s
    Characteristics of in situ <t>biofilm</t> and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Matrix S, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/matrix/BigPrep+Lysing+Matrix+S/pmc13620102-50-31-34
    Average 94 stars, based on 1 article reviews
    matrix s - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Journal: Military Medical Research

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    doi: 10.1016/j.mmr.2026.100010

    Figure Lengend Snippet: Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Article Snippet: For the samples of the ex vivo whole blood model, the plasma concentrations of matrix metallopeptidase 9 (MMP9, #DY911, R&D Systems, Minneapolis, USA), IL-6 (#555220, BD Biosciences, San Jose, USA), and IL-8 (#DY208, R&D Systems) were measured in citrate-anticoagulated plasma using enzyme-linked immunosorbent assay according to the respective manufacturer’s instructions.

    Techniques: Concentration Assay, Incubation, Ex Vivo, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Control, Bacteria

    Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Journal: Military Medical Research

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    doi: 10.1016/j.mmr.2026.100010

    Figure Lengend Snippet: Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Article Snippet: For the samples of the ex vivo whole blood model, the plasma concentrations of matrix metallopeptidase 9 (MMP9, #DY911, R&D Systems, Minneapolis, USA), IL-6 (#555220, BD Biosciences, San Jose, USA), and IL-8 (#DY208, R&D Systems) were measured in citrate-anticoagulated plasma using enzyme-linked immunosorbent assay according to the respective manufacturer’s instructions.

    Techniques: Diagnostic Assay, Fluorescence, Comparison, Concentration Assay, Marker, Control, Incubation, Bacteria

    Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.

    Journal: Military Medical Research

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    doi: 10.1016/j.mmr.2026.100010

    Figure Lengend Snippet: Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.

    Article Snippet: For the samples of the ex vivo whole blood model, the plasma concentrations of matrix metallopeptidase 9 (MMP9, #DY911, R&D Systems, Minneapolis, USA), IL-6 (#555220, BD Biosciences, San Jose, USA), and IL-8 (#DY208, R&D Systems) were measured in citrate-anticoagulated plasma using enzyme-linked immunosorbent assay according to the respective manufacturer’s instructions.

    Techniques: Infection

    Characteristics of in situ biofilm and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Biofilm

    Article Title: Genomic insights into activated antimicrobial resistance of in situ hospital-wastewater biofilm

    doi: 10.1016/j.bioflm.2026.100377

    Figure Lengend Snippet: Characteristics of in situ biofilm and hospital wastewater samples. ( a ) Placement of plastic slides in hospital wastewater for in situ biofilm formation and collection of wastewater sample. ( b ) In situ biofilm samples before and after crystal-violet staining. ( c ) Fluorescent staining of in situ biofilm structure: green, red, and blue represent nucleic acids, proteins, and polysaccharides, respectively. ( d ) Comparison of contamination levels based on antimicrobial resistance between hospital wastewater and in situ biofilm. Statistical analysis using unpaired t -test; ∗∗∗p < 0.0001. DHL: deoxycholate hydrogen sulfide lactose, CTX: cefotaxime. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: For fluorescence staining, nucleic acid was stained with cell-permeant SYTO 9 (Thermo Fisher Scientific, Waltham, MA, USA), proteins were stained with FilmTracerTM SYPROTM Ruby Biofilm Matrix Stain (Thermo Fisher Scientific), and polysaccharides were stained with Concanavalin A conjugated to tetramethylrhodamine (Thermo Fisher Scientific).

    Techniques: In Situ, Staining, Comparison

    Taxonomic and functional gene profiles of in situ biofilm and hospital wastewater based on shotgun metagenomic data. Relative abundance of bacterial taxa at the order ( a ) and family ( b ) levels in in situ biofilm and hospital wastewater samples. ( c ) Distribution of genes associated with resistance to antibiotics, biocides, acids, heat, and metals, as well as virulence, shown at the metagenome-assembled genome (MAG) and contig levels for biofilm (BF) and hospital wastewater (HW). MLS: macrolide-lincosamide-streptogramin.

    Journal: Biofilm

    Article Title: Genomic insights into activated antimicrobial resistance of in situ hospital-wastewater biofilm

    doi: 10.1016/j.bioflm.2026.100377

    Figure Lengend Snippet: Taxonomic and functional gene profiles of in situ biofilm and hospital wastewater based on shotgun metagenomic data. Relative abundance of bacterial taxa at the order ( a ) and family ( b ) levels in in situ biofilm and hospital wastewater samples. ( c ) Distribution of genes associated with resistance to antibiotics, biocides, acids, heat, and metals, as well as virulence, shown at the metagenome-assembled genome (MAG) and contig levels for biofilm (BF) and hospital wastewater (HW). MLS: macrolide-lincosamide-streptogramin.

    Article Snippet: For fluorescence staining, nucleic acid was stained with cell-permeant SYTO 9 (Thermo Fisher Scientific, Waltham, MA, USA), proteins were stained with FilmTracerTM SYPROTM Ruby Biofilm Matrix Stain (Thermo Fisher Scientific), and polysaccharides were stained with Concanavalin A conjugated to tetramethylrhodamine (Thermo Fisher Scientific).

    Techniques: Functional Assay, In Situ

    Network analysis of metagenome-assembled genomes, functional genes, and mobile genetic elements based on shotgun metagenomic data. Networks of metagenome-assembled genomes (MAGs) and genes related to antimicrobial resistance (AMR), biocide and metal resistance, insertion sequences (ISs), integron, and virulence are depicted for biofilm ( a ) and hospital wastewater ( b ) samples. Nodes represent individual sequences and edges indicate co-occurrence within the same MAG or contig.

    Journal: Biofilm

    Article Title: Genomic insights into activated antimicrobial resistance of in situ hospital-wastewater biofilm

    doi: 10.1016/j.bioflm.2026.100377

    Figure Lengend Snippet: Network analysis of metagenome-assembled genomes, functional genes, and mobile genetic elements based on shotgun metagenomic data. Networks of metagenome-assembled genomes (MAGs) and genes related to antimicrobial resistance (AMR), biocide and metal resistance, insertion sequences (ISs), integron, and virulence are depicted for biofilm ( a ) and hospital wastewater ( b ) samples. Nodes represent individual sequences and edges indicate co-occurrence within the same MAG or contig.

    Article Snippet: For fluorescence staining, nucleic acid was stained with cell-permeant SYTO 9 (Thermo Fisher Scientific, Waltham, MA, USA), proteins were stained with FilmTracerTM SYPROTM Ruby Biofilm Matrix Stain (Thermo Fisher Scientific), and polysaccharides were stained with Concanavalin A conjugated to tetramethylrhodamine (Thermo Fisher Scientific).

    Techniques: Functional Assay

    Differential gene expression profiles between biofilm and hospital wastewater based on metatranscriptomic data. ( a ) Number of genes with higher (Up) or lower (Down) expression in biofilm (BF) compared to hospital wastewater (HW) across all genes. ( b ) Number of genes with significantly different expression (p < 0.05) between BF and HW. ( c ) Volcano plot showing genes with significant expression differences (p < 0.05) between BF and HW, where colors describe functional categories. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Biofilm

    Article Title: Genomic insights into activated antimicrobial resistance of in situ hospital-wastewater biofilm

    doi: 10.1016/j.bioflm.2026.100377

    Figure Lengend Snippet: Differential gene expression profiles between biofilm and hospital wastewater based on metatranscriptomic data. ( a ) Number of genes with higher (Up) or lower (Down) expression in biofilm (BF) compared to hospital wastewater (HW) across all genes. ( b ) Number of genes with significantly different expression (p < 0.05) between BF and HW. ( c ) Volcano plot showing genes with significant expression differences (p < 0.05) between BF and HW, where colors describe functional categories. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: For fluorescence staining, nucleic acid was stained with cell-permeant SYTO 9 (Thermo Fisher Scientific, Waltham, MA, USA), proteins were stained with FilmTracerTM SYPROTM Ruby Biofilm Matrix Stain (Thermo Fisher Scientific), and polysaccharides were stained with Concanavalin A conjugated to tetramethylrhodamine (Thermo Fisher Scientific).

    Techniques: Gene Expression, Expressing, Functional Assay

    Maximum-likelihood phylogenetic tree of Citrobacter species, including isolates from in situ biofilm sample and publicly available genomes. The tree was constructed using core genome sequences and annotated with metadata including sequence type (ST), isolation source, country of origin, and β-lactamase gene profiles.

    Journal: Biofilm

    Article Title: Genomic insights into activated antimicrobial resistance of in situ hospital-wastewater biofilm

    doi: 10.1016/j.bioflm.2026.100377

    Figure Lengend Snippet: Maximum-likelihood phylogenetic tree of Citrobacter species, including isolates from in situ biofilm sample and publicly available genomes. The tree was constructed using core genome sequences and annotated with metadata including sequence type (ST), isolation source, country of origin, and β-lactamase gene profiles.

    Article Snippet: For fluorescence staining, nucleic acid was stained with cell-permeant SYTO 9 (Thermo Fisher Scientific, Waltham, MA, USA), proteins were stained with FilmTracerTM SYPROTM Ruby Biofilm Matrix Stain (Thermo Fisher Scientific), and polysaccharides were stained with Concanavalin A conjugated to tetramethylrhodamine (Thermo Fisher Scientific).

    Techniques: In Situ, Construct, Sequencing, Isolation